ad

GPT Healthcare Q2 Results FY27: Net Profit Jumps 45.28% to Rs 15.40 Cr, Revenue Rs 135.62 Cr

5 Nov 2026 • 9:57 pm

GPT Healthcare Q2 Results FY27: Net Profit Jumps 45.28% to Rs 15.40 Cr, Revenue Rs 135.62 Cr

Quick Answer

GPT Healthcare Q2 Results FY27 were declared on 5 November 2026, and the quarterly results show Standalone revenue of Rs 135.62 Cr, up 14.05% from Rs 118.91 Cr a year earlier. Net profit rose 45.28% to Rs 15.40 Cr from Rs 10.60 Cr, so YoY growth was stronger in profit than in sales. Operating Profit rose 18.21% to Rs 26.88 Cr.

GPT Healthcare Ltd (GPTHEALTH) Q2 Results FY27 announced on 5 November 2026, covering the company's financial performance for the July to September quarter. On a standalone basis the company reported revenue of Rs 135.62 Cr and net profit of Rs 15.40 Cr. The GPT Healthcare Q2 Results FY27 release sets out the results date, the standalone results and the YoY comparison in a single summary.

This GPT Healthcare Q2 Results results analysis goes through the financial highlights, the business factors the data discloses, the FY27 outlook and the risks, beginning with the Financial Highlights table that follows. Readers can use the Univest Screener and the Univest app to compare GPT Healthcare with other companies that have reported.

Click Here – Get Free Investment Predictions

GPT Healthcare Q2 Results FY27: Financial Highlights

Metric Q2 FY27 (Sep 26) Q2 FY26 (Sep 25) YoY Change
Revenue Rs 135.62 Cr Rs 118.91 Cr +14.05% YoY
Operating Profit Rs 26.88 Cr Rs 22.74 Cr +18.21% YoY
Net Profit (PAT) Rs 15.4 Cr Rs 10.6 Cr +45.28% YoY

Source: company filing for GPT Healthcare Q2 Results FY27, 5 November 2026. Figures in Rs Crore, Standalone basis.

Key Takeaways from GPT Healthcare Q2 Results: What Stands Out

  • Revenue of Rs 135.62 Cr grew 14.05% from Rs 118.91 Cr, a solid YoY growth reading for the top line.
  • Net profit of Rs 15.40 Cr rose 45.28% from Rs 10.60 Cr, the fastest-growing line in GPT Healthcare Q2 Results FY27.
  • Operating Profit of Rs 26.88 Cr improved 18.21% from Rs 22.74 Cr, a little ahead of revenue growth.
  • Net profit margin improved to 11.4% from 8.9%, while return on equity was 16.32% in FY26.
  • The performance analysis comes next and compares the three lines over the same year.

GPT Healthcare Q2 Results FY27: Performance Analysis

GPT Healthcare Q2 Results FY27 show net profit growing much faster than revenue on a standalone basis. Revenue rose 14.05% YoY to Rs 135.62 Cr, Operating Profit rose 18.21% YoY to Rs 26.88 Cr, and net profit rose 45.28% YoY to Rs 15.40 Cr, so profit expanded at a multiple of the sales growth rate.

The ordering of the three growth rates is the key point in these quarterly results. Revenue moved from Rs 118.91 Cr, Operating Profit from Rs 22.74 Cr and net profit from Rs 10.60 Cr, which fits with the higher net profit margin reported for the quarter.

Investors following GPT Healthcare Q2 Results can check whether the same YoY growth continues in later filings. The supplied figures confirm the movement but do not establish the specific cause behind it. The disclosed drivers come next, which is where the results analysis turns to the business factors.

A closer look at the three lines shows how the quarter fits together. Revenue added Rs 16.71 Cr over the year-ago figure, while net profit added Rs 4.80 Cr, so a large share of the extra sales reached the bottom line as profit. Operating Profit added Rs 4.14 Cr over the same period, which sits between the two.

The margin figures make the same point in a different form. Net profit margin of 11.4% against 8.9% means each rupee of revenue left more profit than it did a year ago, and that is the main reason net profit grew at 45.28% while revenue grew at 14.05%.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis starts with revenue, which grew 14.1% year on year to Rs 135.62 Cr in the latest quarter, the sales base on which the quarterly results for this period were built.

Net Profit and Margin – Net profit rose 45.3% year on year to Rs 15.40 Cr and net profit margin improved to 11.4% from 8.9% in the comparison quarter, two linked movements that define the profit side of GPT Healthcare Q2 Results FY27.

Return on Equity – Return on equity was 16.32% in FY26, a full-year measure that gives investors a reference for how efficiently shareholders' capital was used before the latest quarter was reported.

FY27 Outlook After GPT Healthcare Q2 Results

FY27 full-year results will depend on the quarters that follow. The GPT Healthcare Q2 Results FY27 figures of Rs 135.62 Cr revenue and Rs 15.40 Cr net profit are the reference point for this results analysis as later filings arrive.

The Q3 and Q4 disclosures will show whether the improved margin is held and whether net profit keeps growing YoY. The FY26 return measures noted in the risks are the other items to follow, which leads into the risks.

Investors who track quarterly results usually compare the latest quarter with both the year-ago quarter and the preceding full year. Here the year-ago comparison is positive, while the FY26 return ratios sit below their FY25 levels, so the two views should be read together before drawing any conclusion about the trend.

Key Risks to Watch After GPT Healthcare Q2 Results FY27

Return on Equity Decline

Return on equity declined to 16.32% in FY26 from 21.41% in FY25, a fall that investors can weigh against the profit growth shown in GPT Healthcare Q2 Results FY27 when they read the full year.

Return on Capital Employed Decline

Return on capital employed declined to 23.06% in FY26 from 29.60% in FY25, so capital efficiency is a second measure to watch even as the latest quarter records YoY growth in profit.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

GPT Healthcare Q2 Results FY27 recorded Standalone revenue of Rs 135.62 Cr, Operating Profit of Rs 26.88 Cr and net profit of Rs 15.40 Cr, each higher than the year-ago quarter. The GPT Healthcare Q2 Results figures, read with the lower FY26 return measures, give investors a balanced base for the standalone results and the next quarterly results. Investors should consult a SEBI-registered advisor before acting.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions on GPT Healthcare Q2 Results FY27

What are GPT Healthcare Q2 Results FY27?

Ans. GPT Healthcare Q2 Results FY27 are the standalone quarterly results of GPT Healthcare for July to September 2026, showing revenue of Rs 135.62 Cr, as the Quick Answer box above explains.

What is the results date for GPT Healthcare Q2 Results FY27?

Ans. GPT Healthcare declared its Q2 FY27 numbers on 5 November 2026, which is the results date for this filing, and the Financial Highlights table compares them with last year.

What revenue was reported in GPT Healthcare Q2 Results FY27?

Ans. GPT Healthcare Q2 Results FY27 report standalone revenue of Rs 135.62 Cr against Rs 118.91 Cr a year earlier, an increase of 14.05% that the Performance Analysis section examines further.

What net profit was reported in GPT Healthcare Q2 Results FY27?

Ans. GPT Healthcare reported net profit of Rs 15.40 Cr for the quarter, compared with Rs 10.60 Cr a year ago, so the Performance Analysis shows a YoY gain of 45.28%.

How much YoY growth did revenue show in GPT Healthcare Q2 Results FY27?

Ans. Revenue showed YoY growth of 14.05% in GPT Healthcare Q2 Results FY27, rising from Rs 118.91 Cr to Rs 135.62 Cr, while the Key Takeaways section places that gain beside the profit lines.

Did net profit rise or fall in GPT Healthcare Q2 Results?

Ans. Net profit rose in GPT Healthcare Q2 Results, from Rs 10.60 Cr to Rs 15.40 Cr, which is faster than revenue growth, as the Performance Analysis section shows.

What was the Operating Profit in GPT Healthcare Q2 Results FY27?

Ans. Operating Profit in GPT Healthcare Q2 Results FY27 was Rs 26.88 Cr compared with Rs 22.74 Cr a year earlier, an increase of 18.21% that the Performance Analysis places beside revenue and net profit.

Are GPT Healthcare Q2 Results consolidated results or standalone results?

Ans. The figures in GPT Healthcare Q2 Results are standalone results, so they cover GPT Healthcare on a standalone basis, and every number in the Financial Highlights table follows that basis.

What business factors shaped GPT Healthcare Q2 Results FY27?

Ans. Revenue growth of 14.1%, net profit growth of 45.3% and a net profit margin of 11.4% against 8.9% shaped GPT Healthcare Q2 Results FY27, as the Key Business Factors section describes.

What are the key risks after GPT Healthcare Q2 Results FY27?

Ans. After GPT Healthcare Q2 Results FY27, the risks are a fall in return on equity to 16.32% from 21.41% and in return on capital employed to 23.06% from 29.60%, as the Key Risks section explains.

What is the outlook after GPT Healthcare Q2 Results?

Ans. FY27 full-year results will depend on the quarters that follow GPT Healthcare Q2 Results, so the Q3 and Q4 filings will show whether YoY growth continues, as the Outlook section explains.

Where can I find the complete GPT Healthcare Q2 Results FY27 data?

Ans. The complete GPT Healthcare Q2 Results FY27 data on revenue, Operating Profit and net profit sits in the Financial Highlights table on this page, and the Univest Screener offers more comparison for GPTHEALTH.


Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down